Cargando…
Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/Valsartan
The therapy or prevention of atrial fibrillation (AF) is defined as upstream therapy when conducted with the use of drugs, e.g., angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor antagonists, statins, and omega-3 fatty acids, not included in the classes of antiarrhythmic drugs r...
Autores principales: | De Vecchis, Renato, Paccone, Andrea, Di Maio, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295563/ https://www.ncbi.nlm.nih.gov/pubmed/32595805 http://dx.doi.org/10.14740/cr1073 |
Ejemplares similares
-
Favorable Effects of Sacubitril/Valsartan on the Peak Atrial Longitudinal Strain in Patients With Chronic Heart Failure and a History of One or More Episodes of Atrial Fibrillation: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2020) -
Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019) -
A case series about the favorable effects of sacubitril/valsartan on anthracycline cardiomyopathy
por: De Vecchis, Renato, et al.
Publicado: (2020) -
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019) -
Addressing the Challenge of Atrial Fibrillation Management: How to Differentiate the Approach Depending on Left Ventricular Ejection Fraction
por: De Vecchis, Renato, et al.
Publicado: (2019)